GE Salmon Imports Blocked Until Labeling Requirements Are Established

FDA approved the genetically engineered fish for human consumption last year without mandatory labeling

The Food and Drug Administration (FDA) announced earlier this month it would block all imports of AquaBounty’s recently approved genetically engineered (GE) salmon until the agency had determined how to label the novel product. The agency approved the salmon in October without any mandatory labeling indicating that the product is engineered with DNA from another species.

Photo of Packaged FishPhoto by Quazie The FDA approved Aquabounty’s GE salmon in October without mandatory labeling requirements.

In December’s congressional spending bill, Alaska Sen. Lisa Murkowski succeeded in including a provision directing the agency to develop a label for the GE salmon. Now the agency must act on that directive in order to better inform consumers about the product they are buying.

“This GE salmon should not have been approved in the first place. But thanks to the efforts of Senator Murkowski, along with millions of Americans who have voiced their opposition, the FDA is finally addressing at least one of the primary concerns with this product,” Jaydee Hanson, senior policy analyst at Center for Food Safety, said.

“In addition to fixing the labeling issue, FDA should use this time to re-evaluate its entire approval, which failed to fully assess the potential for environmental and economic damage to native salmon stocks and the communities who rely on them.”

AquaBounty plans to produce the GE salmon eggs on Prince Edward Island, Canada and then grow them to market-size in a facility in Panama, where they would be processed into fillets, and then shipped to the U.S. for sale. Consumers concerned about their personal health or environmental impacts may not be able to avoid the fish. While 9,000 grocery stores and numerous restaurants have vowed not to sell the GE fish, lack of labeling laws mean that average consumers will not have a choice.

“In addition to imports in the U.S., FDA should also be sure to block shipments of eggs from the Prince Edward Island facility to Panama,” Hanson added.

In approving the AquaBounty transgenic salmon, the FDA ignored millions of Americans and more than 40 members of Congress who have expressed vocal opposition. FDA also neglects the concerns of more than 300 environmental, consumer, health and animal welfare organizations, salmon and fishing groups and associations, food companies, chefs and restaurants.

Get the Journal in your inbox.
Sign up for our weekly newsletter.

You Make Our Work Possible

You Make Our Work Possible

We don’t have a paywall because, as a nonprofit publication, our mission is to inform, educate and inspire action to protect our living world. Which is why we rely on readers like you for support. If you believe in the work we do, please consider making a tax-deductible year-end donation to our Green Journalism Fund.

Donate
Get the Journal in your inbox.
Sign up for our weekly newsletter.

The Latest

My Week with a Marbled Murrelet

Thirty years after I cared for a rescued murrelet chick, many questions remain about the species’ future.

Betsy L. Howell

Cyberpunk Nation

How Donald Trump's America is being hacked by White Nationalism.

Juan Cole

Butterfly Population in the US has Shrunk by 22% Over Last 20 Years, Study Shows

Drop in line with rate of overall insect loss as scientists point to habitat loss, pesticide use and the climate crisis

Oliver Milman The Guardian

US Public Land Stewards Decry Firings and Loss of Knowledge

In February, thousands of civil servants were fired from agencies that study the country’s soils, seas, and skies

Gabrielle Canon The Guardian

Oaxaca’s Low-Tech Climate Solutions

Indigenous communities in this Mexican state are adopting inexpensive ecotechnologies to address drought.

Magdaléna Rojo

Most Jurors in Pipeline Case against Greenpeace Have Ties to Fossil Fuel Industry

Trial-monitoring committee in Dakota Access lawsuit have shared concerns of judicial bias and due-process violations

Rachel Leingang The Guardian